Hugh Gannon

Associate Director at KSQ Therapeutics

Speaker

Hugh Gannon, PhD is a scientist in the field of gene-edited cell therapies, specializing in CRISPR-based genome engineering and analytical development. His work focuses on developing and implementing assays to support sgRNA manufacturing, potency characterization, and regulatory readiness. He has deep experience in translating functional genomics insights into robust, scalable workflows for clinical-stage programs, with particular emphasis on ensuring consistency, quality, and performance of gene editing reagents.